x

Search for a clinical trial

* (*) mandatory field

6 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Recruiting trial
Ongoing trial
Oral biphosphonate effect on osseous symptoms in fibrous dysplasia of bone : PROFIDYS (Phase III)
Cliniques Universitaires UCL de Saint Luc - UCLStLuc
Service de rhumatologie

FRANCE

AUVERGNE-RHONE-ALPES
LYON

Recruiting trial
Ongoing trial
PROFIDYS: Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone (Phase II -III) - FR
CHU de Lyon HCL - GH Edouard Herriot
Service de rhumatologie et de pathologie osseuse

FRANCE

AUVERGNE-RHONE-ALPES
LYON

GERMANY

Berlin
BERLIN

Ongoing trial
PROFIDYS: Reduction of Bone Morbidity Using an Oral Bisphosphonate in Fibrous Dysplasia of Bone (Phase III)
Charité - Universitätsmedizin Berlin (CBF)
ZMK - Zentrum für Muskel- und Knochenforschung

NETHERLANDS

Zuid-Holland
LEIDEN

Recruiting trial
Ongoing trial
PROFIDYS: Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
LUMC - Leids Universitair Medisch Centrum
Afdeling Endocrinologie en Stofwisselingsziekten

UNITED KINGDOM

Grampian
ABERDEEN

Ongoing trial
PROFIDYS : Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone (Phase II/III)
TauRx Therapeutics - Institute of Medical Sciences
Department of Medicines and Therapeutics